Akebia Therapeutics
Development and commercialization of therapeutics for patients with chronic kidney disease. Learn more
Launch date
Employees
Market cap
AUD468m
Enterprise valuation
AUD483m (Public information from Sep 2024)
Share price
$1.37 AKBA
Cambridge Massachusetts (HQ)
Authorizing premium user...